News Image

Top movers in Tuesday's after hours session

By Mill Chart

Last update: Sep 27, 2022

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Today's after hours gainers

TickerChangeComment
AYTU21.21%AYTU BIOPHARMA INC's (NASDAQ:AYTU) shares rose 21.21% to $0.23 during Tuesday's after hours session. yesterday the company released their earnings. In the last 3 months the share price dropped with 71.64%.
PNT7.89%POINT BIOPHARMA GLOBAL INC (NASDAQ:PNT) rose 7.89% to $8.75 during Tuesday's after hours session. In the last month the share price dropped with 21.34%.
GLNG5.97%GOLAR LNG LTD's (NASDAQ:GLNG) shares rose 5.97% to $25.04. Shareholders saw the stock price going 76.08% higher is the past year.
AMRX4.9%AMNEAL PHARMACEUTICALS INC's (NYSE:AMRX) stock price increased by 4.9% to $2.14. In the last 3 months the share price dropped with 39.29%.
LVTX4.42%LAVA THERAPEUTICS NV's (NASDAQ:LVTX) shares rose 4.42% to $4.73 during Tuesday's after hours session. Two days ago the company had a press release: Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, a Preclinical Gamma Delta Bispecific T Cell Engager for EGFR-Expressing Solid Tumors.
TCRT4.33%ALAUNOS THERAPEUTICS INC (NASDAQ:TCRT) rose 4.33% to $2.17 during Tuesday's after hours session. In the last 3 months the stock gained 60.0%.
AGEN3.92%AGENUS INC (NASDAQ:AGEN) rose 3.92% to $2.12 during Tuesday's after hours session. In the last month the stock lost 23.31%.
IVZ3.71%INVESCO LTD's (NYSE:IVZ) shares rose 3.71% to $15.09. In the last 6 months the share price dropped with 37.58%.
TOPS3.42%TOP SHIPS INC (NASDAQ:TOPS) rose 3.42% to $2.42 during Tuesday's after hours session. In the last month the stock lost 59.84%.
CNX2.83%CNX RESOURCES CORP's (NYSE:CNX) stock price is advancing with 2.83% to a price of $15.6. A press release (CNX Resources Corporation Announces Closing of $500 Million Senior Notes Offering) was released yesterday.

Our after hours gainers screener will show you the full list.

After hours losers

TickerChangeComment
IBIO-33.58%IBIO INC's (NYSEARCA:IBIO) stock price is declining with 33.58% to a price of $0.21. Shareholders saw the stock price going 21.54% higher in the past 3 months.
MNMD-31.05%MIND MEDICINE MINDMED INC's (NASDAQ:MNMD) stock price decreased by 31.05% to $4.22. In the last month the stock lost 49.04%.
PBTS-16.65%POWERBRIDGE TECHNOLOGIES CO's (NASDAQ:PBTS) stock price is declining with 16.65% to a price of $0.5. Prices are quite volatile now: this is a reversal from 20.0% gain.
GMDA-14.8%GAMIDA CELL LTD's (NASDAQ:GMDA) stock price decreased by 14.8% to $1.67. Earlier today the company had a press release: Gamida Cell Announces Launch of Public Offering of Ordinary Shares.
ASZ.W-10.0%AUSTERLITZ ACQ CL A -CW27's (NYSE:ASZ.W) shares fell 10.0% to $0.09. NYSE:ASZ.W already had a hard day: closing -28.57% lower during the regular session.
AQST-8.76%AQUESTIVE THERAPEUTICS INC's (NASDAQ:AQST) stock price is declining with 8.76% to a price of $1.04. In the last 3 months the share price increased with 80.95%.
SAND-8.62%SANDSTORM GOLD LTD's (NYSE:SAND) stock price is declining with 8.62% to a price of $5.09. A press release (Sandstorm Gold Royalties Announces US$80 Million Bought Deal Financing) was released earlier today.
IMTE-5.8%INTEGRATED MEDIA TECHNOLOGY's (NASDAQ:IMTE) stock price decreased by 5.8% to $0.65. In the last month the share price dropped with 52.15%.
MEIP-5.0%MEI PHARMA INC's (NASDAQ:MEIP) stock price decreased by 5.0% to $0.39. In the last month the share price dropped with 21.95%.
ATXI-4.96%AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) stock price decreased by 4.96% to $6.9. After running up 106.0% in today's session, NASDAQ:ATXI is pulling back after hours.

For the full after hours loser list go to our after hours losers screener.

Back

AVENUE THERAPEUTICS INC

NASDAQ:ATXI (3/27/2024, 8:00:54 PM)

Premarket: 0.1526 0 (0%)

0.1526

+0 (+1.06%)

ATXI News

News Image3 days ago - Avenue TherapeuticsAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Image9 days ago - BusinessInsiderATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avenue Therapeutics (NASDAQ:ATXI) just reported results for the fourth quarter ...

News Image9 days ago - InvestorPlaceATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

ATXI stock results show that Avenue Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

News Image10 days ago - Avenue TherapeuticsAvenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - ...

News Image13 days ago - Avenue TherapeuticsAvenue Therapeutics Receives Positive Listing Determination from Nasdaq

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Image17 days ago - ChartmillGet insights into the top gainers and losers of Monday's pre-market session.

Which stocks are moving before the opening bell on Monday?

News Image17 days ago - Avenue TherapeuticsAvenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

BAER-101 demonstrated full suppression of seizure activity in SynapCell's GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure...

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

-In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg...

News Image3 months ago - Avenue TherapeuticsAvenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused...

News Image3 months ago - Avenue TherapeuticsAvenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

MIAMI, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused...

News Image3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

ATXI Links
Follow us for more